пятница, 8 февраля 2008 г.

Health economic implications of irbesartan treatment versus standard blood pressure control in patients with type 2 diabetes, hypertension and renal disease: a hungarian analysis

You have forgotten your username or password, we can .My Menu Saved Items дё­ж–‡(з®ЂдЅ") дё­ж–‡(з№Ѓй«") English Deutsch н•њкµ­м–ґ ж—Ґжњ¬иЄћ Franais Espaol Ш§Щ„Ш№Ш±ШЁЩЉШ© Р СѓСЃСЃРєРёР№ Journal Article Health economic implications of irbesartan treatment versus standard blood pressure control in patients with type 2 diabetes, hypertension and renal disease: a Hungarian analysis Journal Publisher Springer Berlin / Heidelberg ISSN 1618-7598 (Print) 1618-7601 (Online) Issue Category Original Paper DOI 10.Pages 161-168 Subject Collection SpringerLink Date Saturday, January 20, 2007 Query Builder Close Clear Within all content Within this journal Within this issue Export this article Export this article as RIS Text Text PDF The size of this document is 211 kilobytes.It may be a lengthier download, this is the most authoritative online format.HTML This offers the quickest access for ease of browsing.Note that some scientific and mathematical characters may not render as precisely as in PDF versions. В© Springer.
Read more Responsiveness of the adult attention-deficit/hyperactivity disorder quality of life scale (aaqol)
Get more Resistant hypertension and aldosteronism